IBD is an autoimmune disease that prompts your body’s immune system to mistakenly attack healthy cells in your bowel ... ulcerative colitis are the main types of IBD. They’re both grouped ...

and inflammatory bowel disease (IBD). The findings have been reported in Nature. There are two important kinds of EC cells, which each react to different types of stimuli in the gut. One cell type is ...

Biopsy tissue taken during the procedure is sent to a lab to examine for changes in the cells. Finding inflammation ... There ...

and inflammatory bowel disease (IBD). The study, published in Nature, found that special gut cells, called enterochromaffin (EC) cells, play a more significant role in pain than previously thought ...

Preclinical models are simplified tools that help researchers study these complex interactions in a controlled manner and prioritize relevant biochemical pathways when developing IBD therapies ...

People with IBD often get screened for colorectal cancer every one to three years via colonoscopies. Past research shows that it can be challenging to detect pre-cancerous cells in people with IBD.

A type of protein found inside cells that binds to ... High levels of these molecules are associated with chronic inflammatory diseases, including IBD. Proteins that form connections between cells in ...

The mechanism underlying mucosal damage in IBD could involve a dysregulated, extreme T-cell response to normal enteric bacteria, and inhibition of this immune response could potentially be an ...

Dual biologic therapy may serve as a suitable treatment choice for patients with IBD who have not responded to current therapies.

Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease ... its know-how on cell-based therapies.

Up to 40% of IBD patients may experience EIMs, with higher risks in Crohn disease and specific disease locations. Five key risk factors for EIMs include disease type, sex, ocular manifestations ...